首页 工具
登录
购物车
Bosentan (hydrate)

Bosentan (hydrate)

产品编号 T6265   CAS 157212-55-0
别名: 波生坦水合物, Bosentan Hydrate, Benzenesulfonamide, Actelion, Ro 47-0203

Bosentan hydrate (Ro 47-0203) 是endothelin-1 (ET)竞争性拮抗剂,在人SMC 细胞中,它能够作用于 ETA 受体(Ki:4.7 nM)和 ETB 受体(Ki:95 nM)。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Bosentan (hydrate) Chemical Structure
Bosentan (hydrate), CAS 157212-55-0
规格 价格/CNY 货期 数量
10 mg ¥ 225 现货
25 mg ¥ 347 现货
50 mg ¥ 578 现货
100 mg ¥ 970 现货
200 mg ¥ 1,660 现货
500 mg ¥ 2,920 现货
1 mL * 10 mM (in DMSO) ¥ 613 现货
其他形式的 Bosentan (hydrate):
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
产品目录号及名称: Bosentan (hydrate) (T6265)
点击图片重新获取验证码
选择批次  
纯度: 99.75%
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Bosentan hydrate (Ro 47-0203) is a competitive and dual antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
靶点活性 ETB:95 nM(Ki), ETA:4.7 nM(Ki)
体外活性 Bosentan competitively antagonizes the specific binding of [125 I]-labeled ET-1 on human smooth muscle cells (ET-A receptors)human placenta (ET-B receptors). Bosentan also inhibits the binding of selective ET-B ligands on porcine trachea. Contractions induced by ET-1 in isolated rat aorta (ET-A) and by the selective ET-B agonist sarafotoxin S6C in rat trachea are competitively inhibited by Bosentan (pA2= 7.2 and 6.0, respectively), as is the endothelium-dependent relaxation to sarafotoxin S6C in rabbit superior mesenteric artery (pA2= 6.7). The binding of 40 other peptides, prostaglandins, ions and neurotransmitters is not significantly affected by Bosentan, which shows its specificity for ET receptors. [1]
体内活性 Bosentan inhibits the presser response to big ET-1 both after i.v. and oral administration, with a long duration of action and no intrinsic agonist activity. Bosentan also inhibits the depressor and presser effect of ET-1 and sarafotoxin S6C. Its pharmacological profile makes Bosentan a potentially useful drug in the management of clinical disorders associated with vasoconstriction.[1] Bosentan is the first oral non-peptide mixed ETA/B-receptor antagonist. Long-term treatment with Bosentan has markedly increased the survival, hemodynamics, and cardiac remodeling in rats with CHF. Bosentan decreases arterial BP to a similar degree as an angiotensin-converting enzyme (ACE) inhibitor. Administration of Bosentan in rats with CHF after acute MI significantly decreases arterial BP and has additive effect to that of an ACE inhibitor. Acute and chronical treatment with Bosentan also improves the systemic and pulmonary hemodynamics by a decrease in peripheral and pulmonary vascular resistance, and increase of cardiac output in patients with CHF. [2]
细胞实验 Bosentan is prepared in DMSO and diluted with appropriate medium before use[2]. Cell viability is evaluated by the trypan blue exclusion test. Human dermal fibroblasts are treated with the indicated concentration of Bosentan (10, 20 and 40 μM). Cell viability is examined at 24 and 48 hours. Stained (dead) and unstained (viable) cells are counted with a hematocytometer[2].
别名 波生坦水合物, Bosentan Hydrate, Benzenesulfonamide, Actelion, Ro 47-0203
分子量 569.63
分子式 C27H29N5O6S·H2O
CAS No. 157212-55-0

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 93 mg/mL (163.3 mM)

Ethanol: 2 mg/mL (3.51 mM)

H2O: < 1 mg/mL (insoluble or slightly soluble)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO / Ethanol 1 mM 1.7555 mL 8.7776 mL 17.5553 mL 43.8881 mL
DMSO 5 mM 0.3511 mL 1.7555 mL 3.5111 mL 8.7776 mL
10 mM 0.1756 mL 0.8778 mL 1.7555 mL 4.3888 mL
20 mM 0.0878 mL 0.4389 mL 0.8778 mL 2.1944 mL
50 mM 0.0351 mL 0.1756 mL 0.3511 mL 0.8778 mL
100 mM 0.0176 mL 0.0878 mL 0.1756 mL 0.4389 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Ostrowski RP, et al. Pathophysiology, 2003, 9(4), 249-256. 2. Clozel M, et al. J Pharmacol Exp Ther, 1994, 270(1), 228-235.
Bosentan Macitentan-d4 SB-209670 Aprocitentan Darusentan IRL-1038 acetate Carperitide acetate BQ-123

相关化合物库

该产品包含在如下化合物库中:
抑制剂库 抗癌临床化合物库 EMA 上市药物库 抗癌药物库 药物功能重定位化合物库 GPCR靶点分子库 抗癌上市药物库 膜蛋白靶向化合物库 口服活性化合物库 神经递质受体化合物库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Bosentan (hydrate) 157212-55-0 GPCR/G Protein Endothelin Receptor 波生坦水合物 Bosentan Bosentan Hydrate inhibit Benzenesulfonamide Inhibitor Actelion Ro 47-0203 inhibitor

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼